The clinical effects of nifedipine on periodontal status

Journal of Periodontology

Volumn 69, Issue 2, 1998, Pages 108-112

  Tavassoli, Sepideh ^a   Yamalik, Nermin ^a   Çaǧlayan, Feriha ^a   Çaǧlayan, Gürhan ^a   Eratalay, Kenan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Gingival hyperplasia etiology; Gingivitis etiology; Nifedipine adverse effects

Indexed keywords

NIFEDIPINE;

ADULT; ANGINA PECTORIS; ARTICLE; CHRONIC DISEASE; DOSE RESPONSE; DRUG INDUCED DISEASE; DRUG METABOLISM; FEMALE; GENDER; GINGIVA HYPERPLASIA; GINGIVITIS; HUMAN; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; TOOTH PLAQUE;

EID: 0031935781     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1998.69.2.108     Document Type: Article

References (33)

1. Seymour RA, Heasman PA. Drugs and the periodontium. J Clin Periodontol 1988;15:1-16.
2. Brown RS, Sein P, Corio R, Bottomley WK. Nitrendipine-induced gingival hyperplasia. First case report. Oral Surg Oral Med Oral Pathol 1990;70:593-596.
3. Deen-Duggins L, Fry HR, Caly JR, Turner JR. Nifedipine associated gingival overgrowth. A survey of literature and report of four cases. Quintessence Int 1996;27:163-170.
4. Heijl L, Sundin Y. Nifedipine-induced gingival overgrowth in dogs. J Periodontol 1989;60:104-112.
5. Barclay S, Thomason JM, Idle JR, Seymour RA. The incidence and severity of nifedipine-induced gingival overgrowth. J Clin Periodontol 1992;19:311-314.
6. Brown RS, Beaver WT, Bottomley WK. On the mechanisms of drug-induced gingival hyperplasia. J Oral Pathol Med 1991;20:201-209.
7. Nishikawa S, Tada H, Hamasaki A, et al. Nifedipine-induced gingival hyperplasia: A clinical and in vitro study. J Periodontol 1991; 62:30-35.
8. Lederman D, Lumerman H, Reuben S, Freedman PD. Gingival hyperplasia associated with nifedipine therapy. Report of a case. Oral Surg Oral Med Oral Pathol 1984;57:620-622.
9. Nery EB, Edson RG, Lee KK, Pruthi VK, Watson J. Prevalence of nifedipine-induced gingival hyperplasia. J Periodontol 1995;66: 572-578.
10. Morisaki I, Kato K, Loyola-Rodriguez JP, Nagata T, Ishida H. Nifedipine-induced gingival overgrowth in the presence and absence of gingival inflammation in rats. J Periodont Res 1993;28:396-403.
11. O'Valle F, Mesa FL, Gomez-Morales M, et al. Immunohistochemical study of 30 cases of cyclosporin A-induced gingival overgrowth. J Periodontol 1994;65:724-730.
12. Thomason JM, Seymour RA, Rice N. Nifedipine: The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth. J Clin Periodontol 1993;20:37-40.
13. Thomason JM, Seymour RA, Ellis JS, et al. Iatrogenic gingival overgrowth in cardiac transplantation. J Periodontol 1995;66:742-746.
14. Ishida H, Kondoh T, Kataoka M, et al. Factors influencing nifedipine-induced gingival overgrowth in rats. J Periodontol 1995;66: 345-350.
15. Ramon Y, Behar S, Kishon Y, Engelberg IS. Gingival hyperplasia caused by nifedipine. A preliminary report. Int J Cardiol 1984;5: 195-204.
16. McGaw WMT, Porter H. Cyclosporin-induced gingival overgrowth: An ultrastructural stereologic study. Oral Surg Oral Med Oral Pathol 1988;64:293-297.
17. Löe H. The gingival index, the plaque index and the retention index system. J Periodontol 1967;38:610-616.
18. Russell AI.. A system of classification and scoring for prevalence surveys of periodontal disease. J Dent Res 1956;35:350-359.
19. Mühlemann HR, Son S. Gingival sulcus bleeding - A leading symptom in initial gingivitis. Helv Odontol Acta 1971;15:107-113.
20. Box GEP, Hunter WG, Hunter JS. Statistics for Experimenters: An Introduction to Design, Data Analysis and Model Building. New York: John Wiley and Sons; 1984:165-203.
21. Barak S, Engelberg IS, Hiss J. Gingival hyperplasia caused by nifedipine: Histopathologic findings. J Periodontol 1987;58:639-642.
22. Hancock RH, Swan RH. Nifedipine-induced gingival overgrowth: Report of a case treated by controlling plaque. J Clin Periodontol 1992;19:12-14.
23. Slavin J, Taylor J. Cyclosporin, nifedipine and gingival hyperplasia. (Letter). Lancet 1987;2:739.
24. Sooriyamoorthy M, Gower DB, Eley BM. Androgen metabolism in gingival hyperplasia induced by nifedipine and cyclosporin. J Periodont Res 1990;25:25-30.
25. Tyldsley WR, Rotter E. Gingival hyperplasia induced by cyclosporin A. Br Dent J 1984;157:305-309.
26. Daley TD, Wysocki GP, Colin D. Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1986;62:417-421.
27. Somacarrera ML, Hernandez G, Acero J, Moskow BS. Factors related to the incidence and severity of cyclosporin-induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontol 1994;65:671-675.
28. Ellis JS, Seymour RA, Monkman SC, Idle JR. Gingival sequestration of nifedipine in nifedipine-induced gingival overgrowth. Lancet 1992;339:1382-1383.
29. King GN, Fullinfaw R, Higgins TJ, Walker RG, Francis DMA, Wiesenfeld D. Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium antagonists. J Clin Periodontol 1993; 20:286-293.
30. Fries KM, Blieden T, Looney RJ, et al. Short analytical review. Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin Immunol Immunopathol 1994;72:283-292.
31. McCulloch CAG, Bordin S. Role of fibroblast subpopulations in periodontal physiology and pathology. J Periodont Res 1991;26: 144-154.
32. Romanos GE, Schröter-Kermani C, Hinz N, Herrmann D, Strub JR, Bernimoulin JP. Extracellular matrix analysis of nifedipine-induced gingival overgrowth: Immunohistochemical distribution of different collagen types as well as glycoprotein fibronectin. J Periodont Res 1993;28:10-16.
33. Lucas RM, Howell LP, Wall BA. Nifedipine-induced gingival hyperplasia. A histochemical and ultrastructural study. J Periodontol 1985;56:211-215.